Mineralys Therapeutics Insider Sold Shares Worth $43,350,000, According to a Recent SEC Filing-December 2024-www.financetom.com

Mineralys Therapeutics Insider Sold Shares Worth $43,350,000, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Mineralys Therapeutics Insider Sold Shares Worth $43,350,000, According to a Recent SEC Filing

Nov 24, 2025 1:03 AM

03:38 AM EST, 11/24/2025 (MT Newswires) -- Brian Taylor Slingsby, 10% Owner, Director, on November 20, 2025, sold 1,000,000 shares in Mineralys Therapeutics ( MLYS ) for $43,350,000. Following the Form 4 filing with the SEC, Slingsby has control over a total of 7,903,838 common shares of the company, with 7,903,838 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1933414/000193341425000156/xslF345X05/wk-form4_1763766476.xml

Previous page： Ontario teachers said to mull $100 million Xpressbees investment Next page： Uber forecasts quarterly operating profit above estimates on ride-hailing demand

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Ontario teachers said to mull $100 million Xpressbees investment

Aug 4, 2023

The Canadian pension investor may buy a stake in the firm at about a $1.4 billion valuation. The funds would potentially be used for purposes including acquisitions.

Uber forecasts quarterly operating profit above estimates on ride-hailing demand

Aug 1, 2023

Uber's cost controls ranging from layoffs to lower transaction costs and maintaining a steady headcount have helped the company maintain its target to post operating income profitability this year. At the same time, the number of rides after the pandemic is growing.

Kering boosts its luxury portfolio with Valentino deal as Gucci lags

Jul 28, 2023

The French luxury group missed market forecasts for second quarter sales, eking out growth of just 3 percent and continuing to lag rivals as it seeks to turn around business at Gucci, including by recently overhauling its management.

Global companies report slowing sales in China as post-pandemic boom fades

Aug 2, 2023

Global automakers are also having to contend with increased competition from domestic rivals, which for the first time took a more than 50% share of the market in the first half of 2023. Volkswagen cut its full-year sales target last week due to a sales dip in China, its top market.